Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 1/04: Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 12257247 | Targeted degradation of VAV1 | Apr 11, 24 | Mar 25, 25 | Monte Rosa Therapeutics AG |
| 12258393 | Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha | May 20, 21 | Mar 25, 25 | Janssen Biotech, Inc. |
| 12251406 | Biopolymer compositions for the treatment and prevention of gastric ulcers | Jun 20, 23 | Mar 18, 25 | SIDR, LLC |
| 12226433 | Treatment of irritable bowel syndrome with molybdenum | Jul 22, 19 | Feb 18, 25 | The Johns Hopkins University |
| 12227578 | Modulation of intestinal epithelial cell differentiation, maintenance and/or function through T cell action | Nov 07, 17 | Feb 18, 25 | THE BROAD INSTITUTE, INC.; Massachussetts Institute of Technology; The General Hospital Corporation; |
| 12220425 | Gastroesophageal reflux disease with fibers formed of β-1-4-glucan | Nov 16, 21 | Feb 11, 25 | Not available |
| 12220445 | Inert matrices for qualitative and semi-quantitative seed amplification assays | Sep 09, 22 | Feb 11, 25 | Amprion, Inc. |
| 12215147 | Methods of selecting, based on polymorphisms, an inflammatory bowel disease subject for treatment with an anti-TL1A antibody | Aug 23, 21 | Feb 04, 25 | Prometheus Biosciences, Inc.; Cedars Sinai Medical Center; |
| 12202841 | Therapeutic agents for enhancing epithelial and/or endothelial barrier function | Jan 31, 24 | Jan 21, 25 | ARTUS THERAPEUTICS, INC.; INSTITUTE FOR STEM CELL SCIENCE AND REGENERATIVE MEDICINE; |
| 12195413 | Ethynyl derivatives | Jun 03, 21 | Jan 14, 25 | Hoffmann-La Roche, Inc. |
| 12186364 | Proteins for the treatment of epithelial barrier function disorders | Mar 10, 22 | Jan 07, 25 | Genevive, Inc. |
| 12178800 | Sulforaphane-melatonin-like compound | Aug 27, 19 | Dec 31, 24 | PERPETUUM VENTURES NV |
| 12180211 | Compounds, compositions and methods | Jun 17, 21 | Dec 31, 24 | DENALI THERAPEUTICS, INC. |
| 12168677 | Proteins for the treatment of epithelial barrier function disorders | Jul 18, 23 | Dec 17, 24 | Genevive, Inc. |
| 12157739 | Hypoxanthine compounds | Sep 13, 19 | Dec 03, 24 | Kissei Pharmaceutical Co. Ltd. |
| 12152072 | Methods of treating ulcerative colitis with an anti-IL-23p19 antibody | Mar 28, 19 | Nov 26, 24 | Eli Lilly and Company |
| 12144834 | Methods and compositions for treating gastrointestinal and inflammatory disorders | Sep 13, 19 | Nov 19, 24 | XBIOME INC. |
| 12115257 | Nucleic acid vector tablets | May 09, 18 | Oct 15, 24 | UNIVERSITÉ DE BORDEAUX; Centre National De La Recherche Scientifique (CNRS); Institut Polytechnique de Bordeaux; Ecole Nationale Superieure d'Arts et Metiers; UNIVERSITÉ PARIS CITÉ; PARIS SCIENCES ET LETTRES - QUARTIER LATIN; INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (INSERM); |
| 12109190 | Urolithins as immune response enhancers | Aug 24, 22 | Oct 08, 24 | AMAZENTIS SA |
| 12109222 | Methods and compositions for treating mucositis | Feb 12, 21 | Oct 08, 24 | Tosk, Inc. |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2025/0114,317 | Use of L-cysteine for improving the structure and function of gastric mucosa | Dec 27, 22 | Apr 10, 25 | Not available |
| 2025/0115,653 | FUSION PROTEIN OF INTERLEUKIN 2 AND APPLICATION THEREOF IN IBD | Jul 15, 22 | Apr 10, 25 | Not available |
| 2025/0109,144 | THERAPEUTIC AGENTS FOR ENHANCING EPITHELIAL AND/OR ENDOTHELIAL BARRIER FUNCTION | Dec 13, 24 | Apr 03, 25 | Not available |
| 2025/0101,063 | POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS | Jan 19, 23 | Mar 27, 25 | Not available |
| 2025/0090,604 | STRAIN OF PEDIOCOCCUS ACIDILACTICI WITH FUNCTION OF TREATING ULCERATIVE COLITIS AND APPLICATION THEREOF | Dec 01, 24 | Mar 20, 25 | Not available |
| 2025/0082,713 | Active ingredient groups and their key target combinations for the treatment of UC | Sep 07, 23 | Mar 13, 25 | Not available |
| 2025/0064,761 | SUBSTITUTED BENZAMIDES AND THEIR USE IN THERAPY | Apr 09, 24 | Feb 27, 25 | PHARMACYL AB |
| 2025/0064,769 | HIGHLY PURIFIED EICOSAPENTAENOIC ACID, AS FREE FATTY ACID, REDUCES FECAL CALPROTECTIN LEVELS AND PREVENTS CLINICAL RELAPSE IN ULCERATIVE COLITIS PATIENTS | Nov 12, 24 | Feb 27, 25 | Not available |
| 2025/0064,907 | THERAPEUTIC VACCINES FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | Aug 23, 24 | Feb 27, 25 | Not available |
| 2025/0049,834 | Methods and Compositions for Treating Mucositis | Sep 05, 24 | Feb 13, 25 | Not available |
| 2025/0051,286 | SMALL MOLECULE INHIBITORS OF PR3 AND HNE AND USES THEREOF | Dec 16, 22 | Feb 13, 25 | ORIXA THERAPEUTICS LLC |
| 2025/0051,376 | BENZIMIDAZOLE DERIVATIVE COMPOUNDS AND USE THEREOF | Dec 07, 22 | Feb 13, 25 | Not available |
| 2025/0041,359 | USE OF BIFIDOBACTERIUM LACTIS BL-99 IN PREVENTION AND/OR AMELIORATION OF GASTRITIS | Nov 30, 22 | Feb 06, 25 | Not available |
| 2025/0032,471 | Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | Oct 10, 24 | Jan 30, 25 | Not available |
| 2025/0032,554 | Medicine for Preventing or Treating Enteritis and Intestinal Cancer | Oct 28, 22 | Jan 30, 25 | Not available |
| 2025/0032,568 | TRADITIONAL CHINESE MEDICINE COMPOSITION AND TRADITIONAL CHINESE MEDICINE DECOCTION FOR TREATING GASTROESOPHAGEAL REFLUX DISEASE (GERD), AND PREPARATION METHOD AND USE THEREOF | Aug 29, 24 | Jan 30, 25 | Not available |
| 2025/0034,243 | METHODS OF TREATING ULCERATIVE COLITIS | Oct 16, 24 | Jan 30, 25 | Not available |
| 2025/0018,000 | METHOD FOR TREATING AND PREVENTING ULCERATIVE COLITIS AND METHOD FOR DAI REDUCTION | Sep 30, 24 | Jan 16, 25 | BEIJING WEHAND-BIO PHARMACEUTICAL CO., LTD; GUANGXI WEHAND-BIO PHARMACEUTICAL CO., LTD; |
| 2025/0018,057 | METHODS OF TREATMENT OF HLA-B27 RELATED INFLAMMATORY DISEASES AND COMPOSITIONS RELATED TO SAME | May 07, 24 | Jan 16, 25 | Not available |
| 2025/0019,353 | BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS | Jul 02, 24 | Jan 16, 25 | Not available |
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
